Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2)

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 6, 2006, Pages 970-976

  Duan, Xue Zhang ^a   He, Hong Xia ^a   Zhuang, Hui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

ELISPOT; HBcAg; HBsAg; Vaccine

Indexed keywords

DENDRITIC CELL VACCINE; GAMMA INTERFERON; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ADULT; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; EVALUATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; PHENOTYPE; PRIORITY JOURNAL; SURFACE PROPERTY; T LYMPHOCYTE;

EID: 33744720122     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04262.x     Document Type: Article

References (37)

1. Kao JH Chen DS. Global control of hepatitis B virus infection. Lancet Infect. Dis. 2002 2:395 403.
2. Chisari FV Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 1995 13:29 60.
3. Nayersina R Fowler P Guilhot S et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 1993 150:4659 71.
4. Lohr HF Pingel S Bocher WO et al. Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B: restoration by exogenous interleukin-12. Clin. Exp. Immunol. 2002 130:107 14.
5. Penna A Artini M Cavalli A et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J. Clin. Invest. 1996 98:1185 94.
6. Rehermann B Ferrari C Pasquinelli C Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat. Med. 1996 2:1104 8.
7. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001 106:259 62.
8. Banchereau J Briere F Caux C et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000 18:767 811.
9. Goldszmid RS Idoyaga J Bravo AI Steinman R Mordoh J Wainstok R. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J. Immunol. 2003 171:5940 7.
10. Moll H. Dendritic cells as a tool to combat infectious diseases. Immunol. Lett. 2003 85:153 7.
11. Wang FS Xing LH Liu MX et al. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J. Gastroenterol. 2001 7:537 41.
12. Arima S Akbar SM Michitaka K et al. Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization. Int. J. Mol. Med. 2003 11:169 74.
13. Beckebaum S Cicinnati VR Zhang X et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 2003 109:487 95.
14. Guan R. Interferon monotherapy in chronic hepatitis B. J. Gastroenterol. Hepatol. 2000 15 Suppl. E34 40.
15. Yao G Cui Z Wang B Yao J Zeng M. An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B. Chin. Med. J. (Engl.) 2002 115:1814 18.
16. Shimizu Y Guidotti LG Fowler P Chisari FV. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J. Immunol. 1998 161:4520 9.
17. Michel ML. Towards immunotherapy for chronic hepatitis B virus infections. Vaccine 2002 20 Suppl. 4 A83 8.
18. Auffermann-Gretzinger S Keeffe EB Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001 97:3171 6.
19. Lore K Larsson M. The role of dendritic cells in the pathogenesis of HIV-1 infection. Apmis 2003 111:776 88.
20. Kruse M Rosorius O Kratzer F et al. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T cell stimulatory capacity. J. Virol. 2000 74:7127 36.
21. Grosjean I Caux C Bella C et al. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J. Exp. Med. 1997 186:801 12.
22. Beckebaum S Cicinnati VR Dworacki G et al. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin. Immunol. 2002 104:138 50.
23. Kunitani H Shimizu Y Murata H Higuchi K Watanabe A. Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases. J. Hepatol. 2002 36:734 41.
24. Moser M. Dendritic cells in immunity and tolerance: do they display opposite functions? Immunity 2003 19:5 8.
25. Berger TG Feuerstein B Strasser E et al. Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. J. Immunol. Methods 2002 268:131 40.
26. Romani N Reider D Heuer M et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 1996 196:137 51.
27. Lee AW Truong T Bickham K et al. A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy. Vaccine 2002 20 Suppl. 4 A8 22.
28. Krug A Rothenfusser S Selinger S et al. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells. J. Immunol. 2003 170:3468 77.
29. Verdijk RM Mutis T Esendam B et al. Polyriboinosinic polyribocytidylic acid (poly (I:C)) induces stable maturation of functionally active human dendritic cells. J. Immunol. 1999 163:57 61.
30. Kuroki H Morisaki T Matsumoto K et al. Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use. Cancer Immunol. Immunother. 2003 52:561 8.
31. Humrich J Jenne L. Viral vectors for dendritic cell-based immunotherapy. Curr. Top. Microbiol. Immunol. 2003 276:241 59.
32. Banchereau J Palucka AK Dhodapkar M et al. Immune and clinical responses in patients with metastatic melanoma to CD34 (+) progenitor-derived dendritic cell vaccine. Cancer Res. 2001 61:6451 8.
33. Lu W Wu X Lu Y Guo W Andrieu JM. Therapeutic dendritic-cell vaccine for simian AIDS. Nat. Med. 2003 9:27 32.
34. Van der Molen RG Sprengers D Binda RS et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004 40:738 46.
35. Wen YM Qu D Zhou SH. Antigen-antibody complex as therapeutic vaccine for viral hepatitis B. Int. Rev. Immunol. 1999 18:251 8.
36. Zheng BJ Ng MH He LF et al. Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice. Vaccine 2001 19:4219 25.
37. Ding CL Yao K Zhang TT Zhou F Xu L Xu JY. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells. World J. Gastroenterol. 2003 9:1512 15.